TENAX THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
TENAX THERAPEUTICS, INC. (TENX) had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-28
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-03-31: Operating Lease, Right-of-Use Asset $0.00.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $179.50K 10-K · filed 2024-03-28 |
| 2022-09-30 | $207.36K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $234.66K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $261.44K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $287.69K 10-K · filed 2023-03-31 |
| 2021-09-30 | $313.44K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $338.70K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $29.69K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $58.78K 10-K · filed 2022-03-29 |
| 2020-09-30 | $87.28K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $115.22K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $142.61K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $169.45K 10-K/A · filed 2021-04-16 |
| 2019-09-30 | $195.77K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $221.58K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $246.89K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |